nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—Hoarseness—Sorafenib—liver cancer	0.0338	0.0416	CcSEcCtD
Tiotropium—Dysphonia—Sorafenib—liver cancer	0.0181	0.0223	CcSEcCtD
Tiotropium—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0165	0.0203	CcSEcCtD
Tiotropium—Glossitis—Sorafenib—liver cancer	0.0161	0.0199	CcSEcCtD
Tiotropium—Influenza like illness—Sorafenib—liver cancer	0.0145	0.0178	CcSEcCtD
Tiotropium—Mouth ulceration—Sorafenib—liver cancer	0.0135	0.0166	CcSEcCtD
Tiotropium—Ulcerative stomatitis—Epirubicin—liver cancer	0.0119	0.0147	CcSEcCtD
Tiotropium—Ulcerative stomatitis—Doxorubicin—liver cancer	0.011	0.0136	CcSEcCtD
Tiotropium—Pain in extremity—Sorafenib—liver cancer	0.0108	0.0133	CcSEcCtD
Tiotropium—Dehydration—Sorafenib—liver cancer	0.01	0.0124	CcSEcCtD
Tiotropium—Dry skin—Sorafenib—liver cancer	0.0099	0.0122	CcSEcCtD
Tiotropium—Dysphagia—Sorafenib—liver cancer	0.00933	0.0115	CcSEcCtD
Tiotropium—Oral candidiasis—Epirubicin—liver cancer	0.00866	0.0107	CcSEcCtD
Tiotropium—Renal failure—Sorafenib—liver cancer	0.00818	0.0101	CcSEcCtD
Tiotropium—Stomatitis—Sorafenib—liver cancer	0.00811	0.00998	CcSEcCtD
Tiotropium—Oral candidiasis—Doxorubicin—liver cancer	0.00801	0.00986	CcSEcCtD
Tiotropium—Epistaxis—Sorafenib—liver cancer	0.00785	0.00966	CcSEcCtD
Tiotropium—Laryngitis—Epirubicin—liver cancer	0.00763	0.00939	CcSEcCtD
Tiotropium—Urinary tract disorder—Sorafenib—liver cancer	0.00738	0.00908	CcSEcCtD
Tiotropium—Connective tissue disorder—Sorafenib—liver cancer	0.00734	0.00904	CcSEcCtD
Tiotropium—Urethral disorder—Sorafenib—liver cancer	0.00732	0.00901	CcSEcCtD
Tiotropium—Herpes zoster—Epirubicin—liver cancer	0.0073	0.00899	CcSEcCtD
Tiotropium—Skin ulcer—Epirubicin—liver cancer	0.00706	0.00869	CcSEcCtD
Tiotropium—Laryngitis—Doxorubicin—liver cancer	0.00706	0.00869	CcSEcCtD
Tiotropium—Gingivitis—Epirubicin—liver cancer	0.00701	0.00862	CcSEcCtD
Tiotropium—Angiopathy—Sorafenib—liver cancer	0.00678	0.00834	CcSEcCtD
Tiotropium—Herpes zoster—Doxorubicin—liver cancer	0.00676	0.00831	CcSEcCtD
Tiotropium—Immune system disorder—Sorafenib—liver cancer	0.00675	0.0083	CcSEcCtD
Tiotropium—Mediastinal disorder—Sorafenib—liver cancer	0.00673	0.00829	CcSEcCtD
Tiotropium—Dysphonia—Epirubicin—liver cancer	0.00668	0.00822	CcSEcCtD
Tiotropium—Arrhythmia—Sorafenib—liver cancer	0.00667	0.00821	CcSEcCtD
Tiotropium—Mental disorder—Sorafenib—liver cancer	0.00655	0.00806	CcSEcCtD
Tiotropium—Skin ulcer—Doxorubicin—liver cancer	0.00654	0.00804	CcSEcCtD
Tiotropium—Malnutrition—Sorafenib—liver cancer	0.0065	0.008	CcSEcCtD
Tiotropium—Gingivitis—Doxorubicin—liver cancer	0.00648	0.00798	CcSEcCtD
Tiotropium—Dysphonia—Doxorubicin—liver cancer	0.00618	0.00761	CcSEcCtD
Tiotropium—Glossitis—Epirubicin—liver cancer	0.00597	0.00734	CcSEcCtD
Tiotropium—Angioedema—Sorafenib—liver cancer	0.00594	0.00731	CcSEcCtD
Tiotropium—Syncope—Sorafenib—liver cancer	0.00583	0.00718	CcSEcCtD
Tiotropium—Bone pain—Epirubicin—liver cancer	0.00574	0.00706	CcSEcCtD
Tiotropium—Loss of consciousness—Sorafenib—liver cancer	0.00572	0.00703	CcSEcCtD
Tiotropium—Cough—Sorafenib—liver cancer	0.00568	0.00698	CcSEcCtD
Tiotropium—Hypertension—Sorafenib—liver cancer	0.00562	0.00691	CcSEcCtD
Tiotropium—Myalgia—Sorafenib—liver cancer	0.00554	0.00681	CcSEcCtD
Tiotropium—Arthralgia—Sorafenib—liver cancer	0.00554	0.00681	CcSEcCtD
Tiotropium—Glossitis—Doxorubicin—liver cancer	0.00552	0.00679	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0055	0.00677	CcSEcCtD
Tiotropium—Ventricular tachycardia—Epirubicin—liver cancer	0.0055	0.00677	CcSEcCtD
Tiotropium—Dry mouth—Sorafenib—liver cancer	0.00542	0.00666	CcSEcCtD
Tiotropium—Influenza like illness—Epirubicin—liver cancer	0.00534	0.00657	CcSEcCtD
Tiotropium—Bone pain—Doxorubicin—liver cancer	0.00531	0.00654	CcSEcCtD
Tiotropium—Infection—Sorafenib—liver cancer	0.00527	0.00649	CcSEcCtD
Tiotropium—Candida infection—Epirubicin—liver cancer	0.00525	0.00646	CcSEcCtD
Tiotropium—Shock—Sorafenib—liver cancer	0.00522	0.00643	CcSEcCtD
Tiotropium—Nervous system disorder—Sorafenib—liver cancer	0.00521	0.00641	CcSEcCtD
Tiotropium—Skin disorder—Sorafenib—liver cancer	0.00516	0.00634	CcSEcCtD
Tiotropium—Ventricular tachycardia—Doxorubicin—liver cancer	0.00509	0.00626	CcSEcCtD
Tiotropium—Mouth ulceration—Epirubicin—liver cancer	0.00497	0.00612	CcSEcCtD
Tiotropium—Influenza like illness—Doxorubicin—liver cancer	0.00494	0.00608	CcSEcCtD
Tiotropium—Candida infection—Doxorubicin—liver cancer	0.00486	0.00598	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00484	0.00595	CcSEcCtD
Tiotropium—Dyspepsia—Sorafenib—liver cancer	0.00467	0.00575	CcSEcCtD
Tiotropium—Mouth ulceration—Doxorubicin—liver cancer	0.0046	0.00566	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Sorafenib—liver cancer	0.00458	0.00564	CcSEcCtD
Tiotropium—Constipation—Sorafenib—liver cancer	0.00454	0.00559	CcSEcCtD
Tiotropium—Gastrointestinal pain—Sorafenib—liver cancer	0.00434	0.00534	CcSEcCtD
Tiotropium—Urticaria—Sorafenib—liver cancer	0.00422	0.00519	CcSEcCtD
Tiotropium—Abdominal pain—Sorafenib—liver cancer	0.0042	0.00516	CcSEcCtD
Tiotropium—Pain in extremity—Epirubicin—liver cancer	0.00399	0.00491	CcSEcCtD
Tiotropium—Hypersensitivity—Sorafenib—liver cancer	0.00391	0.00481	CcSEcCtD
Tiotropium—Pruritus—Sorafenib—liver cancer	0.00376	0.00462	CcSEcCtD
Tiotropium—Dehydration—Epirubicin—liver cancer	0.00371	0.00457	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—liver cancer	0.00369	0.00454	CcSEcCtD
Tiotropium—Dry skin—Epirubicin—liver cancer	0.00366	0.0045	CcSEcCtD
Tiotropium—Dizziness—Sorafenib—liver cancer	0.00351	0.00432	CcSEcCtD
Tiotropium—Dysphagia—Epirubicin—liver cancer	0.00345	0.00425	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—liver cancer	0.00343	0.00423	CcSEcCtD
Tiotropium—Dry skin—Doxorubicin—liver cancer	0.00339	0.00417	CcSEcCtD
Tiotropium—Vomiting—Sorafenib—liver cancer	0.00338	0.00415	CcSEcCtD
Tiotropium—Angina pectoris—Epirubicin—liver cancer	0.00336	0.00414	CcSEcCtD
Tiotropium—Rash—Sorafenib—liver cancer	0.00335	0.00412	CcSEcCtD
Tiotropium—Dermatitis—Sorafenib—liver cancer	0.00334	0.00411	CcSEcCtD
Tiotropium—Headache—Sorafenib—liver cancer	0.00333	0.00409	CcSEcCtD
Tiotropium—Dysuria—Epirubicin—liver cancer	0.00323	0.00397	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Epirubicin—liver cancer	0.00321	0.00395	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—liver cancer	0.00319	0.00393	CcSEcCtD
Tiotropium—Nausea—Sorafenib—liver cancer	0.00315	0.00388	CcSEcCtD
Tiotropium—Hyperglycaemia—Epirubicin—liver cancer	0.00311	0.00383	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—liver cancer	0.00311	0.00383	CcSEcCtD
Tiotropium—Renal failure—Epirubicin—liver cancer	0.00302	0.00372	CcSEcCtD
Tiotropium—Stomatitis—Epirubicin—liver cancer	0.003	0.00369	CcSEcCtD
Tiotropium—Urinary tract infection—Epirubicin—liver cancer	0.00299	0.00368	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—liver cancer	0.00298	0.00367	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00297	0.00365	CcSEcCtD
Tiotropium—Epistaxis—Epirubicin—liver cancer	0.0029	0.00357	CcSEcCtD
Tiotropium—Sinusitis—Epirubicin—liver cancer	0.00289	0.00355	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—liver cancer	0.00288	0.00354	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—liver cancer	0.0028	0.00344	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—liver cancer	0.00277	0.00341	CcSEcCtD
Tiotropium—Rhinitis—Epirubicin—liver cancer	0.00277	0.00341	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—liver cancer	0.00277	0.0034	CcSEcCtD
Tiotropium—Pharyngitis—Epirubicin—liver cancer	0.00274	0.00337	CcSEcCtD
Tiotropium—Urinary tract disorder—Epirubicin—liver cancer	0.00273	0.00336	CcSEcCtD
Tiotropium—Oedema peripheral—Epirubicin—liver cancer	0.00272	0.00335	CcSEcCtD
Tiotropium—Connective tissue disorder—Epirubicin—liver cancer	0.00271	0.00334	CcSEcCtD
Tiotropium—Urethral disorder—Epirubicin—liver cancer	0.00271	0.00333	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—liver cancer	0.00268	0.0033	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—liver cancer	0.00267	0.00329	CcSEcCtD
Tiotropium—Visual impairment—Epirubicin—liver cancer	0.00266	0.00327	CcSEcCtD
Tiotropium—Eye disorder—Epirubicin—liver cancer	0.00258	0.00318	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—liver cancer	0.00256	0.00315	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—liver cancer	0.00254	0.00312	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—liver cancer	0.00252	0.0031	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—liver cancer	0.00252	0.0031	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—liver cancer	0.00251	0.00309	CcSEcCtD
Tiotropium—Angiopathy—Epirubicin—liver cancer	0.00251	0.00308	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—liver cancer	0.0025	0.00308	CcSEcCtD
Tiotropium—Immune system disorder—Epirubicin—liver cancer	0.00249	0.00307	CcSEcCtD
Tiotropium—Mediastinal disorder—Epirubicin—liver cancer	0.00249	0.00306	CcSEcCtD
Tiotropium—Arrhythmia—Epirubicin—liver cancer	0.00247	0.00304	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—liver cancer	0.00246	0.00303	CcSEcCtD
Tiotropium—Mental disorder—Epirubicin—liver cancer	0.00242	0.00298	CcSEcCtD
Tiotropium—Malnutrition—Epirubicin—liver cancer	0.0024	0.00296	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—liver cancer	0.00239	0.00294	CcSEcCtD
Tiotropium—Back pain—Epirubicin—liver cancer	0.00233	0.00286	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—liver cancer	0.00232	0.00285	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—liver cancer	0.00231	0.00284	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—liver cancer	0.0023	0.00283	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—liver cancer	0.00228	0.00281	CcSEcCtD
Tiotropium—Vision blurred—Epirubicin—liver cancer	0.00227	0.00279	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—liver cancer	0.00224	0.00275	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—liver cancer	0.00222	0.00274	CcSEcCtD
Tiotropium—Syncope—Epirubicin—liver cancer	0.00216	0.00265	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—liver cancer	0.00215	0.00265	CcSEcCtD
Tiotropium—Palpitations—Epirubicin—liver cancer	0.00212	0.00261	CcSEcCtD
Tiotropium—Loss of consciousness—Epirubicin—liver cancer	0.00211	0.0026	CcSEcCtD
Tiotropium—Cough—Epirubicin—liver cancer	0.0021	0.00258	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—liver cancer	0.0021	0.00258	CcSEcCtD
Tiotropium—Hypertension—Epirubicin—liver cancer	0.00208	0.00255	CcSEcCtD
Tiotropium—Arthralgia—Epirubicin—liver cancer	0.00205	0.00252	CcSEcCtD
Tiotropium—Chest pain—Epirubicin—liver cancer	0.00205	0.00252	CcSEcCtD
Tiotropium—Myalgia—Epirubicin—liver cancer	0.00205	0.00252	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00203	0.0025	CcSEcCtD
Tiotropium—Dry mouth—Epirubicin—liver cancer	0.002	0.00246	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—liver cancer	0.00199	0.00245	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—liver cancer	0.00197	0.00242	CcSEcCtD
Tiotropium—Oedema—Epirubicin—liver cancer	0.00196	0.00241	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—liver cancer	0.00195	0.00241	CcSEcCtD
Tiotropium—Infection—Epirubicin—liver cancer	0.00195	0.0024	CcSEcCtD
Tiotropium—Cough—Doxorubicin—liver cancer	0.00194	0.00239	CcSEcCtD
Tiotropium—Shock—Epirubicin—liver cancer	0.00193	0.00238	CcSEcCtD
Tiotropium—Nervous system disorder—Epirubicin—liver cancer	0.00192	0.00237	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—liver cancer	0.00192	0.00236	CcSEcCtD
Tiotropium—Tachycardia—Epirubicin—liver cancer	0.00191	0.00236	CcSEcCtD
Tiotropium—Skin disorder—Epirubicin—liver cancer	0.00191	0.00234	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—liver cancer	0.00189	0.00233	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—liver cancer	0.00189	0.00233	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—liver cancer	0.00189	0.00233	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00188	0.00231	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—liver cancer	0.00185	0.00228	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—liver cancer	0.00182	0.00223	CcSEcCtD
Tiotropium—Infection—Doxorubicin—liver cancer	0.0018	0.00222	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00179	0.0022	CcSEcCtD
Tiotropium—Shock—Doxorubicin—liver cancer	0.00179	0.0022	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—liver cancer	0.00178	0.00219	CcSEcCtD
Tiotropium—Insomnia—Epirubicin—liver cancer	0.00177	0.00218	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—liver cancer	0.00177	0.00218	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—liver cancer	0.00176	0.00217	CcSEcCtD
Tiotropium—Paraesthesia—Epirubicin—liver cancer	0.00176	0.00217	CcSEcCtD
Tiotropium—Dyspepsia—Epirubicin—liver cancer	0.00173	0.00213	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Epirubicin—liver cancer	0.00169	0.00208	CcSEcCtD
Tiotropium—Constipation—Epirubicin—liver cancer	0.00168	0.00206	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00165	0.00204	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—liver cancer	0.00164	0.00202	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—liver cancer	0.00163	0.00201	CcSEcCtD
Tiotropium—Gastrointestinal pain—Epirubicin—liver cancer	0.0016	0.00197	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—liver cancer	0.0016	0.00197	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00157	0.00193	CcSEcCtD
Tiotropium—Urticaria—Epirubicin—liver cancer	0.00156	0.00192	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—liver cancer	0.00155	0.00191	CcSEcCtD
Tiotropium—Abdominal pain—Epirubicin—liver cancer	0.00155	0.00191	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—liver cancer	0.00148	0.00183	CcSEcCtD
Tiotropium—Hypersensitivity—Epirubicin—liver cancer	0.00145	0.00178	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—liver cancer	0.00144	0.00177	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—liver cancer	0.00143	0.00177	CcSEcCtD
Tiotropium—Pruritus—Epirubicin—liver cancer	0.00139	0.00171	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—liver cancer	0.00134	0.00165	CcSEcCtD
Tiotropium—Dizziness—Epirubicin—liver cancer	0.0013	0.0016	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—liver cancer	0.00128	0.00158	CcSEcCtD
Tiotropium—Vomiting—Epirubicin—liver cancer	0.00125	0.00153	CcSEcCtD
Tiotropium—Rash—Epirubicin—liver cancer	0.00124	0.00152	CcSEcCtD
Tiotropium—Dermatitis—Epirubicin—liver cancer	0.00124	0.00152	CcSEcCtD
Tiotropium—Headache—Epirubicin—liver cancer	0.00123	0.00151	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—liver cancer	0.0012	0.00148	CcSEcCtD
Tiotropium—Nausea—Epirubicin—liver cancer	0.00117	0.00143	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—liver cancer	0.00115	0.00142	CcSEcCtD
Tiotropium—Rash—Doxorubicin—liver cancer	0.00114	0.00141	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—liver cancer	0.00114	0.00141	CcSEcCtD
Tiotropium—Headache—Doxorubicin—liver cancer	0.00114	0.0014	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—liver cancer	0.00108	0.00133	CcSEcCtD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CD—liver cancer	6.75e-05	0.00036	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	6.69e-05	0.000357	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTM1—liver cancer	6.64e-05	0.000354	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CPT1B—liver cancer	6.52e-05	0.000348	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GLUL—liver cancer	6.52e-05	0.000348	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HPGDS—liver cancer	6.42e-05	0.000343	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KDR—liver cancer	6.37e-05	0.00034	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK14—liver cancer	6.33e-05	0.000338	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1A1—liver cancer	6.29e-05	0.000336	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NR1H4—liver cancer	6.28e-05	0.000335	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRKCE—liver cancer	6.22e-05	0.000332	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ESR1—liver cancer	6.21e-05	0.000332	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRKCE—liver cancer	6.2e-05	0.000331	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTA3—liver cancer	6.18e-05	0.00033	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	6.15e-05	0.000328	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRKCE—liver cancer	6.14e-05	0.000328	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—F2—liver cancer	6.13e-05	0.000327	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	6.13e-05	0.000327	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	6.07e-05	0.000324	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	5.9e-05	0.000315	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF2—liver cancer	5.9e-05	0.000315	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	5.89e-05	0.000314	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF2—liver cancer	5.88e-05	0.000314	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CG—liver cancer	5.87e-05	0.000313	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APC—liver cancer	5.87e-05	0.000313	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTHFR—liver cancer	5.87e-05	0.000313	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	5.83e-05	0.000311	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF2—liver cancer	5.82e-05	0.000311	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARA—liver cancer	5.75e-05	0.000307	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMA4—liver cancer	5.72e-05	0.000306	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMD10—liver cancer	5.72e-05	0.000306	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTA4—liver cancer	5.65e-05	0.000302	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GOT2—liver cancer	5.57e-05	0.000297	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—BRAF—liver cancer	5.52e-05	0.000295	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTA2—liver cancer	5.51e-05	0.000294	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CSF2—liver cancer	5.5e-05	0.000294	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—RAF1—liver cancer	5.49e-05	0.000293	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CSF2—liver cancer	5.49e-05	0.000293	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—RAF1—liver cancer	5.47e-05	0.000292	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CSF2—liver cancer	5.43e-05	0.00029	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—H2AFX—liver cancer	5.43e-05	0.00029	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL2—liver cancer	5.42e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—RAF1—liver cancer	5.42e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—H2AFX—liver cancer	5.41e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL2—liver cancer	5.41e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	5.36e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—H2AFX—liver cancer	5.36e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL2—liver cancer	5.35e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	5.34e-05	0.000285	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTA1—liver cancer	5.31e-05	0.000284	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	5.29e-05	0.000283	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NAT2—liver cancer	5.25e-05	0.00028	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP2E1—liver cancer	5.24e-05	0.00028	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CD—liver cancer	5.16e-05	0.000276	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	5.11e-05	0.000273	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—liver cancer	5.1e-05	0.000272	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—KRAS—liver cancer	5.05e-05	0.00027	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDOB—liver cancer	5.04e-05	0.000269	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CG—liver cancer	4.93e-05	0.000263	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL2—liver cancer	4.92e-05	0.000263	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL2—liver cancer	4.91e-05	0.000262	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TERT—liver cancer	4.91e-05	0.000262	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYCS—liver cancer	4.9e-05	0.000262	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TERT—liver cancer	4.89e-05	0.000261	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL2—liver cancer	4.86e-05	0.000259	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TERT—liver cancer	4.84e-05	0.000259	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GOT1—liver cancer	4.81e-05	0.000257	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GGT1—liver cancer	4.81e-05	0.000257	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CRABP1—liver cancer	4.8e-05	0.000256	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—liver cancer	4.76e-05	0.000254	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	4.64e-05	0.000248	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAF1—liver cancer	4.61e-05	0.000246	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MTOR—liver cancer	4.5e-05	0.00024	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CB—liver cancer	4.5e-05	0.00024	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KDR—liver cancer	4.49e-05	0.00024	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KDR—liver cancer	4.47e-05	0.000239	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK14—liver cancer	4.46e-05	0.000238	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK14—liver cancer	4.44e-05	0.000237	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KDR—liver cancer	4.43e-05	0.000236	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK14—liver cancer	4.4e-05	0.000235	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ESR1—liver cancer	4.37e-05	0.000233	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ESR1—liver cancer	4.36e-05	0.000233	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CD—liver cancer	4.33e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—F2—liver cancer	4.32e-05	0.000231	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTP1—liver cancer	4.32e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ESR1—liver cancer	4.32e-05	0.00023	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—F2—liver cancer	4.31e-05	0.00023	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HRAS—liver cancer	4.3e-05	0.000229	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—liver cancer	4.28e-05	0.000228	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—F2—liver cancer	4.26e-05	0.000228	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—liver cancer	4.26e-05	0.000227	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDKN1B—liver cancer	4.22e-05	0.000225	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HPGDS—liver cancer	4.2e-05	0.000224	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT1—liver cancer	4.18e-05	0.000223	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CASP3—liver cancer	4.14e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APC—liver cancer	4.13e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CG—liver cancer	4.13e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL2—liver cancer	4.13e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APC—liver cancer	4.12e-05	0.00022	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CG—liver cancer	4.12e-05	0.00022	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—liver cancer	4.11e-05	0.000219	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APC—liver cancer	4.08e-05	0.000218	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CG—liver cancer	4.08e-05	0.000218	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCND1—liver cancer	4.03e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—JUN—liver cancer	4.02e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CTNNB1—liver cancer	3.99e-05	0.000213	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—liver cancer	3.97e-05	0.000212	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—liver cancer	3.91e-05	0.000209	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDKN1A—liver cancer	3.9e-05	0.000208	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—BRAF—liver cancer	3.89e-05	0.000207	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—BRAF—liver cancer	3.87e-05	0.000207	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—BRAF—liver cancer	3.84e-05	0.000205	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK8—liver cancer	3.8e-05	0.000203	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT1—liver cancer	3.79e-05	0.000202	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CB—liver cancer	3.78e-05	0.000202	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A1—liver cancer	3.76e-05	0.000201	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMA4—liver cancer	3.74e-05	0.0002	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMD10—liver cancer	3.74e-05	0.0002	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GOT2—liver cancer	3.64e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CD—liver cancer	3.63e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CD—liver cancer	3.62e-05	0.000193	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	3.6e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—liver cancer	3.59e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	3.59e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CD—liver cancer	3.59e-05	0.000191	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—liver cancer	3.58e-05	0.000191	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—KRAS—liver cancer	3.56e-05	0.00019	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	3.55e-05	0.00019	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—liver cancer	3.55e-05	0.000189	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—KRAS—liver cancer	3.55e-05	0.000189	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—KRAS—liver cancer	3.51e-05	0.000187	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—liver cancer	3.51e-05	0.000187	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—liver cancer	3.51e-05	0.000187	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STAT3—liver cancer	3.48e-05	0.000186	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARA—liver cancer	3.44e-05	0.000184	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP2E1—liver cancer	3.42e-05	0.000183	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	3.27e-05	0.000174	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	3.26e-05	0.000174	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAF1—liver cancer	3.24e-05	0.000173	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAF1—liver cancer	3.23e-05	0.000173	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—liver cancer	3.23e-05	0.000172	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	3.23e-05	0.000172	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—liver cancer	3.22e-05	0.000172	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYCS—liver cancer	3.2e-05	0.000171	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAF1—liver cancer	3.2e-05	0.000171	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MTOR—liver cancer	3.17e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CB—liver cancer	3.17e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CB—liver cancer	3.16e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MTOR—liver cancer	3.16e-05	0.000169	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GOT1—liver cancer	3.14e-05	0.000168	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GGT1—liver cancer	3.14e-05	0.000168	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CB—liver cancer	3.13e-05	0.000167	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MTOR—liver cancer	3.13e-05	0.000167	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HRAS—liver cancer	3.02e-05	0.000161	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HRAS—liver cancer	3.01e-05	0.000161	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HRAS—liver cancer	2.99e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KRAS—liver cancer	2.98e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN1B—liver cancer	2.97e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN1B—liver cancer	2.96e-05	0.000158	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CG—liver cancer	2.95e-05	0.000157	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT1—liver cancer	2.94e-05	0.000157	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN1B—liver cancer	2.93e-05	0.000157	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT1—liver cancer	2.93e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CASP3—liver cancer	2.91e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL2—liver cancer	2.91e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CASP3—liver cancer	2.9e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT1—liver cancer	2.9e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL2—liver cancer	2.9e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—liver cancer	2.89e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—liver cancer	2.89e-05	0.000154	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CASP3—liver cancer	2.88e-05	0.000154	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL2—liver cancer	2.87e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—liver cancer	2.86e-05	0.000153	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—liver cancer	2.84e-05	0.000152	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCND1—liver cancer	2.84e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JUN—liver cancer	2.83e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCND1—liver cancer	2.83e-05	0.000151	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTP1—liver cancer	2.82e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JUN—liver cancer	2.82e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNB1—liver cancer	2.81e-05	0.00015	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNB1—liver cancer	2.8e-05	0.000149	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCND1—liver cancer	2.8e-05	0.000149	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JUN—liver cancer	2.79e-05	0.000149	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—liver cancer	2.78e-05	0.000149	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNB1—liver cancer	2.77e-05	0.000148	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—liver cancer	2.75e-05	0.000147	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—liver cancer	2.74e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN1A—liver cancer	2.74e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CA—liver cancer	2.74e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN1A—liver cancer	2.73e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—liver cancer	2.72e-05	0.000145	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN1A—liver cancer	2.71e-05	0.000145	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK8—liver cancer	2.68e-05	0.000143	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT1—liver cancer	2.67e-05	0.000143	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK8—liver cancer	2.67e-05	0.000142	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT1—liver cancer	2.66e-05	0.000142	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—liver cancer	2.65e-05	0.000142	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK8—liver cancer	2.64e-05	0.000141	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT1—liver cancer	2.64e-05	0.000141	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—liver cancer	2.59e-05	0.000138	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CD—liver cancer	2.59e-05	0.000138	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—liver cancer	2.56e-05	0.000137	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HRAS—liver cancer	2.54e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.47e-05	0.000132	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.46e-05	0.000132	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A1—liver cancer	2.46e-05	0.000131	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STAT3—liver cancer	2.45e-05	0.000131	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.44e-05	0.00013	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STAT3—liver cancer	2.44e-05	0.00013	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—liver cancer	2.43e-05	0.00013	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STAT3—liver cancer	2.42e-05	0.000129	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CA—liver cancer	2.3e-05	0.000123	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—liver cancer	2.29e-05	0.000122	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—liver cancer	2.27e-05	0.000121	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.27e-05	0.000121	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—liver cancer	2.27e-05	0.000121	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.26e-05	0.000121	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CB—liver cancer	2.26e-05	0.000121	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARA—liver cancer	2.25e-05	0.00012	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—liver cancer	2.25e-05	0.00012	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT1—liver cancer	2.24e-05	0.00012	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.24e-05	0.00012	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KRAS—liver cancer	2.1e-05	0.000112	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KRAS—liver cancer	2.1e-05	0.000112	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KRAS—liver cancer	2.07e-05	0.000111	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CA—liver cancer	1.93e-05	0.000103	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CG—liver cancer	1.93e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CA—liver cancer	1.92e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CA—liver cancer	1.91e-05	0.000102	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKT1—liver cancer	1.88e-05	0.0001	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—liver cancer	1.87e-05	9.97e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—liver cancer	1.86e-05	9.94e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—liver cancer	1.86e-05	9.93e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—liver cancer	1.84e-05	9.84e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HRAS—liver cancer	1.79e-05	9.54e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HRAS—liver cancer	1.78e-05	9.51e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HRAS—liver cancer	1.76e-05	9.41e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—liver cancer	1.71e-05	9.13e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—liver cancer	1.7e-05	9.1e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CD—liver cancer	1.69e-05	9.04e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—liver cancer	1.69e-05	9.01e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—liver cancer	1.67e-05	8.92e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT1—liver cancer	1.58e-05	8.42e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT1—liver cancer	1.57e-05	8.39e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT1—liver cancer	1.56e-05	8.31e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CB—liver cancer	1.48e-05	7.88e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CA—liver cancer	1.38e-05	7.35e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKT1—liver cancer	1.12e-05	6e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CA—liver cancer	9e-06	4.8e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKT1—liver cancer	7.35e-06	3.92e-05	CbGpPWpGaD
